Both in Biotechnology
Gilead Sciences vs Biogen
Over the past year GILD returned +35.2% and BIIB returned +65.1%; their daily moves had a correlation of 0.34.
GILD +35.2% BIIB +65.1%Growth of $1, one year, split-adjusted
| Metric | GILD | BIIB |
|---|---|---|
| Price | $152.21 | $228.69 |
| Market cap | $188.73B | $33.79B |
| Today | +0.85% | +0.48% |
| 1 month | +2.3% | +3.2% |
| 6 months | +13.4% | +24.4% |
| Year to date | +24.0% | +29.9% |
| 1 year | +37.1% | +68.6% |
| Revenue growth (YoY) | +10.2% | +3.4% |
| Gross margin | 79.8% | 71.6% |
| Net margin | −134.5% | 3.6% |
| P/E (TTM) | — | 40.5× |
| Price / sales | 6.2× | 3.4× |
| Net cash | -$23.07B | -$6.81B |
| Dividend yield | 2.15% | — |
| Volatility (60d) | 27.0% | 36.0% |
| Short % of float | 1.5% | 3.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).